{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:45Z","timestamp":1792783065261,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["(MSIT; approval number, 2019R1G1A1100749)"],"award-info":[{"award-number":["(MSIT; approval number, 2019R1G1A1100749)"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-023-04464-z","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T13:33:14Z","timestamp":1687527194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5873-5283","authenticated-orcid":false,"given":"In Sub","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-9475","authenticated-orcid":false,"given":"Dong Hoon","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-0809","authenticated-orcid":false,"given":"Seung Min","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2734-2134","authenticated-orcid":false,"given":"Bong Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-6398","authenticated-orcid":false,"given":"Moon Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9721-5734","authenticated-orcid":false,"given":"Gwang Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2100-8522","authenticated-orcid":false,"given":"Geun Am","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"4464_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","volume":"56","author":"RM Soetikno","year":"2002","unstructured":"Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56:48\u201354. https:\/\/doi.org\/10.1067\/mge.2002.125367","journal-title":"Gastrointest Endosc"},{"key":"4464_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus","year":"2005","unstructured":"Loftus EV, Harewood GC, Loftus CG et al (2005) PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54:91\u201396. https:\/\/doi.org\/10.1136\/gut.2004.046615","journal-title":"Gut"},{"key":"4464_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","volume":"32","author":"MB de Valle","year":"2012","unstructured":"de Valle MB, Bj\u00f6rnsson E, Lindkvist B (2012) Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int 32:441\u2013448. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02614.x","journal-title":"Liver Int"},{"key":"4464_CR4","doi-asserted-by":"publisher","unstructured":"Lindor KD, Kowdley KV, Harrison ME, American College of Gastroenterology (2015) ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol 110:646\u2013659; quiz 660. https:\/\/doi.org\/10.1038\/ajg.2015.112","DOI":"10.1038\/ajg.2015.112"},{"key":"4464_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/00365520600787994","volume":"42","author":"A Bergquist","year":"2007","unstructured":"Bergquist A, Said K, Broom\u00e9 U (2007) Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Scand J Gastroenterol 42:88\u201393. https:\/\/doi.org\/10.1080\/00365520600787994","journal-title":"Scand J Gastroenterol"},{"key":"4464_CR6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","volume":"159","author":"PJ Trivedi","year":"2020","unstructured":"Trivedi PJ, Crothers H, Mytton J et al (2020) Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age. Gastroenterology 159:915\u2013928. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.049","journal-title":"Gastroenterology"},{"key":"4464_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","volume":"125","author":"K Bambha","year":"2003","unstructured":"Bambha K, Kim WR, Talwalkar J et al (2003) Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125:1364\u20131369. https:\/\/doi.org\/10.1016\/j.gastro.2003.07.011","journal-title":"Gastroenterology"},{"key":"4464_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","volume":"151","author":"AK Lunder","year":"2016","unstructured":"Lunder AK, Hov JR, Borthne A et al (2016) Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease. Gastroenterology 151:660-669.e4. https:\/\/doi.org\/10.1053\/j.gastro.2016.06.021","journal-title":"Gastroenterology"},{"key":"4464_CR9","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","volume":"21","author":"AB de Vries","year":"2015","unstructured":"de Vries AB, Janse M, Blokzijl H, Weersma RK (2015) Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 21:1956\u20131971. https:\/\/doi.org\/10.3748\/wjg.v21.i6.1956","journal-title":"World J Gastroenterol"},{"key":"4464_CR10","doi-asserted-by":"publisher","unstructured":"Yang BR, Choi NK, Kim MS et al (2018) Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients. PLOS One 13:e0200363. https:\/\/doi.org\/10.1371\/journal.pone.0200363","DOI":"10.1371\/journal.pone.0200363"},{"key":"4464_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5217\/ir.2021.00042","volume":"20","author":"MT Weng","year":"2022","unstructured":"Weng MT, Shih IL, Tung CC et al (2022) Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease. Intest Res 20:224\u2013230. https:\/\/doi.org\/10.5217\/ir.2021.00042","journal-title":"Intest Res"},{"key":"4464_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/ibd.21569","volume":"17","author":"BD Ye","year":"2011","unstructured":"Ye BD, Yang SK, Boo SJ et al (2011) Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflamm Bowel Dis 17:1901\u20131906. https:\/\/doi.org\/10.1002\/ibd.21569","journal-title":"Inflamm Bowel Dis"},{"key":"4464_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","volume":"40","author":"YH Lee","year":"2016","unstructured":"Lee YH, Han K, Ko SH et al (2016) Data analytic process of a nationwide population-based study using National Health Information database established by National Health Insurance Service. Diabetes Metab J 40:79\u201382. https:\/\/doi.org\/10.4093\/dmj.2016.40.1.79","journal-title":"Diabetes Metab J"},{"key":"4464_CR14","unstructured":"Yeom M (2009) Direction of policy and management for rare intractable disease patients support program, vol 3. Health Insurance Review and Assessment Service (HIRA) Policy Review, pp 6\u201310"},{"key":"4464_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MIB.0000000000000313","volume":"21","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Hann HJ, Hong SN et al (2015) Incidence and natural course of inflammatory bowel disease in Korea, 2006\u20132012: a nationwide population-based study. Inflamm Bowel Dis 21:623\u2013630. https:\/\/doi.org\/10.1097\/MIB.0000000000000313","journal-title":"Inflamm Bowel Dis"},{"key":"4464_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/apt.13851","volume":"45","author":"SN Hong","year":"2017","unstructured":"Hong SN, Kim HJ, Kim KH et al (2017) Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea. Aliment Pharmacol Ther 45:253\u2013263. https:\/\/doi.org\/10.1111\/apt.13851","journal-title":"Aliment Pharmacol Ther"},{"key":"4464_CR17","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1056\/NEJMc1613273","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF (2016) Primary sclerosing cholangitis. N Engl J Med 375:2501\u20132502. https:\/\/doi.org\/10.1056\/NEJMc1613273","journal-title":"N Engl J Med"},{"key":"4464_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.1840010612","volume":"1","author":"J Ludwig","year":"1981","unstructured":"Ludwig J, Barham SS, LaRusso NF et al (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1:632\u2013640. https:\/\/doi.org\/10.1002\/hep.1840010612","journal-title":"Hepatology"},{"key":"4464_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ijcard.2016.08.296","volume":"223","author":"SR Lee","year":"2016","unstructured":"Lee SR, Choi EK, Rhee TM et al (2016) Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: a nationwide population-based study. Int J Cardiol 223:953\u2013957. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.296","journal-title":"Int J Cardiol"},{"key":"4464_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.29204","volume":"66","author":"MR Deneau","year":"2017","unstructured":"Deneau MR, El-Matary W, Valentino PL et al (2017) The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology 66:518\u2013527. https:\/\/doi.org\/10.1002\/hep.29204","journal-title":"Hepatology"},{"key":"4464_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes J, Cattan S, Blain A et al (2002) Long-term evolution of disease behavior of Crohn\u2019s disease. Inflamm Bowel Dis 8:244\u2013250. https:\/\/doi.org\/10.1097\/00054725-200207000-00002","journal-title":"Inflamm Bowel Dis"},{"key":"4464_CR22","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","volume":"5","author":"IC Solberg","year":"2007","unstructured":"Solberg IC, Vatn MH, H\u00f8ie O et al (2007) Clinical course in Crohn\u2019s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 5:1430\u20131438. https:\/\/doi.org\/10.1016\/j.cgh.2007.09.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4464_CR23","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1007\/s10620-017-4640-9","volume":"62","author":"YS Jung","year":"2017","unstructured":"Jung YS, Han M, Kim WH, Park S, Cheon JH (2017) Incidence and clinical outcomes of inflammatory bowel disease in South Korea, 2011\u20132014: a nationwide population-based study. Dig Dis Sci 62:2102\u20132112. https:\/\/doi.org\/10.1007\/s10620-017-4640-9","journal-title":"Dig Dis Sci"},{"key":"4464_CR24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M (2017) Primary sclerosing cholangitis \u2013 a comprehensive review. J Hepatol 67:1298\u20131323. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.022","journal-title":"J Hepatol"},{"key":"4464_CR25","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1002\/ibd.22938","volume":"18","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, van Erpecum KJ, van Nieuwkerk KM et al (2012) Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis 18:2270\u20132276. https:\/\/doi.org\/10.1002\/ibd.22938","journal-title":"Inflamm Bowel Dis"},{"key":"4464_CR26","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. Lancet 382:1587\u20131599. https:\/\/doi.org\/10.1016\/S0140-6736(13)60096-3","journal-title":"Lancet"},{"key":"4464_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0002-9610(65)90018-8","volume":"110","author":"MP Smith","year":"1965","unstructured":"Smith MP, Loe RH (1965) Sclerosing cholangitis; review of recent case reports and associated diseases and four new cases. Am J Surg 110:239\u2013246. https:\/\/doi.org\/10.1016\/0002-9610(65)90018-8","journal-title":"Am J Surg"},{"key":"4464_CR28","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/hep.24247","volume":"53","author":"NA Molodecky","year":"2011","unstructured":"Molodecky NA, Kareemi H, Parab R et al (2011) Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 53:1590\u20131599. https:\/\/doi.org\/10.1002\/hep.24247","journal-title":"Hepatology"},{"key":"4464_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56:1181\u20131188. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.025","journal-title":"J Hepatol"},{"key":"4464_CR30","doi-asserted-by":"publisher","unstructured":"Kumagai J, Taida T, Ogasawara S et al (2018) Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLOS One 13:e0209352. https:\/\/doi.org\/10.1371\/journal.pone.0209352","DOI":"10.1371\/journal.pone.0209352"},{"key":"4464_CR31","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","volume":"161","author":"B Barberio","year":"2021","unstructured":"Barberio B, Massimi D, Cazzagon N et al (2021) Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis. Gastroenterology 161:1865\u20131877. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.032","journal-title":"Gastroenterology"},{"key":"4464_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/liv.13548","volume":"38","author":"J\u00d8 S\u00f8rensen","year":"2018","unstructured":"S\u00f8rensen J\u00d8, Nielsen OH, Andersson M et al (2018) Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977\u20132011. Liver Int 38:532\u2013541. https:\/\/doi.org\/10.1111\/liv.13548","journal-title":"Liver Int"},{"key":"4464_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/apt.14393","volume":"47","author":"C Nordenvall","year":"2018","unstructured":"Nordenvall C, Ol\u00e9n O, Nilsson PJ et al (2018) Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients. Aliment Pharmacol Ther 47:238\u2013245. https:\/\/doi.org\/10.1111\/apt.14393","journal-title":"Aliment Pharmacol Ther"},{"key":"4464_CR34","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","volume":"20","author":"PJ Trivedi","year":"2022","unstructured":"Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C (2022) Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies. Clin Gastroenterol Hepatol 20:1687-1700.e4. https:\/\/doi.org\/10.1016\/j.cgh.2021.08.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4464_CR35","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","volume":"135","author":"MD Kappelman","year":"2008","unstructured":"Kappelman MD, Rifas-Shiman SL, Porter CQ et al (2008) Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults. Gastroenterology 135:1907\u20131913. https:\/\/doi.org\/10.1053\/j.gastro.2008.09.012","journal-title":"Gastroenterology"},{"key":"4464_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1155\/2012\/984575","volume":"26","author":"A Rocchi","year":"2012","unstructured":"Rocchi A, Benchimol EI, Bernstein CN et al (2012) Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol 26:811\u2013817. https:\/\/doi.org\/10.1155\/2012\/984575","journal-title":"Can J Gastroenterol"},{"key":"4464_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12:720\u2013727. https:\/\/doi.org\/10.1038\/nrgastro.2015.150","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4464_CR38","doi-asserted-by":"publisher","unstructured":"Pillai N, Dusheiko M, Burnand B, Pittet V (2017) A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLOS One 12:e0185500. https:\/\/doi.org\/10.1371\/journal.pone.0185500","DOI":"10.1371\/journal.pone.0185500"},{"key":"4464_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11894-020-0744-z","volume":"22","author":"JA Beard","year":"2020","unstructured":"Beard JA, Franco DL, Click BH (2020) The burden of cost in inflammatory bowel disease: a medical economic perspective and the future of value-based care. Curr Gastroenterol Rep 22:6. https:\/\/doi.org\/10.1007\/s11894-020-0744-z","journal-title":"Curr Gastroenterol Rep"},{"key":"4464_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ecco-jcc\/jjz096","volume":"14","author":"B Lo","year":"2020","unstructured":"Lo B, Vind I, Vester-Andersen MK, Bendtsen F, Burisch J (2020) Direct and indirect costs of inflammatory bowel disease: ten years of follow-up in a Danish population-based inception cohort. J Crohns Colitis 14:53\u201363. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz096","journal-title":"J Crohns Colitis"},{"key":"4464_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MOG.0000000000000642","volume":"36","author":"JA Beard","year":"2020","unstructured":"Beard JA, Click BH (2020) The burden of cost in inflammatory bowel disease: a medical economic perspective. Curr Opin Gastroenterol 36:310\u2013316. https:\/\/doi.org\/10.1097\/MOG.0000000000000642","journal-title":"Curr Opin Gastroenterol"},{"key":"4464_CR42","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1136\/gut.2004.041616","volume":"53","author":"A Bassi","year":"2004","unstructured":"Bassi A, Dodd S, Williamson P, Bodger K (2004) Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53:1471\u20131478. https:\/\/doi.org\/10.1136\/gut.2004.041616","journal-title":"Gut"},{"key":"4464_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2006.05.052","volume":"131","author":"S Odes","year":"2006","unstructured":"Odes S, Vardi H, Friger M et al (2006) Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 131:719\u2013728. https:\/\/doi.org\/10.1053\/j.gastro.2006.05.052","journal-title":"Gastroenterology"},{"key":"4464_CR44","doi-asserted-by":"publisher","unstructured":"Targownik LE, Kaplan GG, Witt J et al (2020) Longitudinal trends in the direct costs and health care utilization ascribable to inflammatory bowel disease in the biologic era: results from a Canadian population-based analysis. Am J Gastroenterol 115:128\u2013137. https:\/\/doi.org\/10.14309\/ajg.0000000000000503","DOI":"10.14309\/ajg.0000000000000503"},{"key":"4464_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/00365521.2019.1591498","volume":"54","author":"JW Kim","year":"2019","unstructured":"Kim JW, Lee CK, Lee JK et al (2019) Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006\u20132015). Scand J Gastroenterol 54:419\u2013426. https:\/\/doi.org\/10.1080\/00365521.2019.1591498","journal-title":"Scand J Gastroenterol"},{"key":"4464_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/gastro\/gou074","volume":"4","author":"U Navaneethan","year":"2016","unstructured":"Navaneethan U, Venkatesh PG, Jegadeesan R et al (2016) Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn\u2019s disease. Gastroenterol Rep (Oxf) 4:43\u201349. https:\/\/doi.org\/10.1093\/gastro\/gou074","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"4464_CR47","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/gut.2010.235408","volume":"60","author":"L Marelli","year":"2011","unstructured":"Marelli L, Xirouchakis E, Kalambokis G et al (2011) Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Gut 60:1224\u20131228. https:\/\/doi.org\/10.1136\/gut.2010.235408","journal-title":"Gut"},{"key":"4464_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cld.2015.08.014","volume":"20","author":"T Folseraas","year":"2016","unstructured":"Folseraas T, Boberg KM (2016) Cancer risk and surveillance in primary sclerosing cholangitis. Clin Liver Dis 20:79\u201398. https:\/\/doi.org\/10.1016\/j.cld.2015.08.014","journal-title":"Clin Liver Dis"},{"key":"4464_CR49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.gastrohep.2019.02.004","volume":"42","author":"FP N\u00fa\u00f1ez","year":"2019","unstructured":"N\u00fa\u00f1ez FP, Quera PR, Gomoll\u00f3n F (2019) Primary sclerosing cholangitis and inflammatory bowel disease: intestine-liver interrelation. Gastroenterol Hepatol 42:316\u2013325. https:\/\/doi.org\/10.1016\/j.gastrohep.2019.02.004","journal-title":"Gastroenterol Hepatol"},{"key":"4464_CR50","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/liv.15339","volume":"42","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao X, He Z et al (2022) Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review and meta-analysis. Liver Int 42:1814\u20131822. https:\/\/doi.org\/10.1111\/liv.15339","journal-title":"Liver Int"},{"key":"4464_CR51","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hep.1840220511","volume":"22","author":"U Broom\u00e9","year":"1995","unstructured":"Broom\u00e9 U, L\u00f6fberg R, Veress B, Eriksson LS (1995) Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22:1404\u20131408. https:\/\/doi.org\/10.1002\/hep.1840220511","journal-title":"Hepatology"},{"key":"4464_CR52","first-page":"26","volume":"38","author":"R Terg","year":"2008","unstructured":"Terg R, Sambuelli A, Coronel E et al (2008) Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study. Acta Gastroenterol Latinoam 38:26\u201333","journal-title":"Acta Gastroenterol Latinoam"},{"key":"4464_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","volume":"28","author":"HH Zheng","year":"2016","unstructured":"Zheng HH, Jiang XL (2016) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies. Eur J Gastroenterol Hepatol 28:383\u2013390. https:\/\/doi.org\/10.1097\/MEG.0000000000000576","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4464_CR54","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.24570","volume":"54","author":"N Razumilava","year":"2011","unstructured":"Razumilava N, Gores GJ, Lindor KD (2011) Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54:1842\u20131852. https:\/\/doi.org\/10.1002\/hep.24570","journal-title":"Hepatology"},{"key":"4464_CR55","doi-asserted-by":"publisher","unstructured":"Ngu JH, Gearry RB, Wright AJ, Stedman CA (2011) Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 9:1092\u20131097; quiz e135. https:\/\/doi.org\/10.1016\/j.cgh.2011.08.027","DOI":"10.1016\/j.cgh.2011.08.027"},{"key":"4464_CR56","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weism\u00fcller","year":"2017","unstructured":"Weism\u00fcller TJ, Trivedi PJ, Bergquist A et al (2017) Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 152:1975-1984.e8. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.038","journal-title":"Gastroenterology"},{"key":"4464_CR57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/gut.51.4.562","volume":"51","author":"CY Ponsioen","year":"2002","unstructured":"Ponsioen CY, Vrouenraets SM, Prawirodirdjo W et al (2002) Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 51:562\u2013566. https:\/\/doi.org\/10.1136\/gut.51.4.562","journal-title":"Gut"},{"key":"4464_CR58","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/jgh.14027","volume":"33","author":"JW Kim","year":"2018","unstructured":"Kim JW, Lee CK, Rhee SY et al (2018) Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: a nationwide population-based study. J Gastroenterol Hepatol 33:847\u2013854. https:\/\/doi.org\/10.1111\/jgh.14027","journal-title":"J Gastroenterol Hepatol"},{"key":"4464_CR59","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/jgh.14542","volume":"34","author":"MS Kwak","year":"2019","unstructured":"Kwak MS, Cha JM, Lee HH et al (2019) Emerging trends of inflammatory bowel disease in South Korea: a nationwide population-based study. J Gastroenterol Hepatol 34:1018\u20131026. https:\/\/doi.org\/10.1111\/jgh.14542","journal-title":"J Gastroenterol Hepatol"},{"key":"4464_CR60","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ibd.20310","volume":"14","author":"SK Yang","year":"2008","unstructured":"Yang SK, Yun S, Kim JH et al (2008) Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986\u20132005: a KASID study. Inflamm Bowel Dis 14:542\u2013549. https:\/\/doi.org\/10.1002\/ibd.20310","journal-title":"Inflamm Bowel Dis"},{"key":"4464_CR61","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","volume":"33","author":"M Joo","year":"2009","unstructured":"Joo M, Abreu-e-Lima P, Farraye F et al (2009) Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol 33:854\u2013862. https:\/\/doi.org\/10.1097\/PAS.0b013e318196d018","journal-title":"Am J Surg Pathol"},{"key":"4464_CR62","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/liv.13265","volume":"37","author":"S Restellini","year":"2017","unstructured":"Restellini S, Chazouill\u00e8res O, Frossard JL (2017) Hepatic manifestations of inflammatory bowel diseases. Liver Int 37:475\u2013489. https:\/\/doi.org\/10.1111\/liv.13265","journal-title":"Liver Int"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-023-04464-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T06:28:09Z","timestamp":1703140089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-023-04464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4464"],"URL":"https:\/\/doi.org\/10.1007\/s00384-023-04464-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2880505\/v1","asserted-by":"object"}]},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"7 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board of Pusan National University Hospital (No. 2002\u2013004-087) approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The Institutional Review Board of Pusan National University Hospital waived the need for informed consent because of the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"175"}}